| Identification | Back Directory | [Name]
6-amino-7-(1H-benzimidazol-2-yl)-5-[3-(diethylamino)propyl]-5H-pyrrolo[2,3-b]pyrazine-2,3-dicarbonitrile | [CAS]
451515-89-2 | [Synonyms]
WAY-323966
Topoisomerase II inhibitor 13
6-amino-7-(1H-benzimidazol-2-yl)-5-[3-(diethylamino)propyl]-5H-pyrrolo[2,3-b]pyrazine-2,3-dicarbonitrile
5H-Pyrrolo[2,3-b]pyrazine-2,3-dicarbonitrile, 6-amino-7-(1H-benzimidazol-2-yl)-5-[3-(diethylamino)propyl]-
6-Amino-7-(1H-benzo[d]imidazol-2-yl)-5-(3-(diethylamino)propyl)-5H-pyrrolo[2,3-b]pyrazine-2,3-dicarbonitrile | [Molecular Formula]
C22H23N9 | [MOL File]
451515-89-2.mol | [Molecular Weight]
413.48 |
| Hazard Information | Back Directory | [Uses]
Topoisomerase II inhibitor 13 is a topoisomerase II (Topo II) inhibitor. Topoisomerase II inhibitor 13 shows antiproliferative activity against several cancer cells. Topoisomerase II inhibitor 13 induces cancer cells apoptosis[1]. | [IC 50]
Topoisomerase II | [References]
[1] Li P H, et al. Synthesis and mechanism studies of 1, 3-benzoazolyl substituted pyrrolo [2, 3-b] pyrazine derivatives as nonintercalative topoisomerase II catalytic inhibitors. Journal of Medicinal Chemistry, 2016, 59(1): 238-252. |
|
|